Compare AQMS & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AQMS | CCM |
|---|---|---|
| Founded | 2014 | 1997 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical/Nursing Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.9M | 17.6M |
| IPO Year | 2015 | 2009 |
| Metric | AQMS | CCM |
|---|---|---|
| Price | $4.84 | $3.90 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 736.3K | 11.4K |
| Earning Date | 11-12-2025 | 09-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $51,056,841.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $550.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.37 | $3.54 |
| 52 Week High | $39.40 | $10.77 |
| Indicator | AQMS | CCM |
|---|---|---|
| Relative Strength Index (RSI) | 37.83 | 43.29 |
| Support Level | $4.72 | $4.13 |
| Resistance Level | $5.54 | $5.40 |
| Average True Range (ATR) | 0.53 | 0.50 |
| MACD | -0.05 | -0.08 |
| Stochastic Oscillator | 6.44 | 7.41 |
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.